Hopewell Therapeutics sublicenses its proprietary lipid nanoparticles for novel cancer vaccine to Foxcroft Therapeutics: Woburn, Massachusetts Saturday, March 7, 2026, 17:00 Hrs [ ...
Transaction is Hopewell’s first commercial license of proprietary lipid nanoparticles (LNPs)Hopewell’s LNPs are the preferred ...
A recent integrative analysis of single-cell sequencing and single-cell spatial mapping of lymph node metastasis in breast cancer reveals novel mechanisms of the metabolic-immune interaction that ...
Fred Hutch Cancer Center scientists have developed an experimental strategy to give genetically engineered CAR T cells help they'd normally find within lymph nodes — but on the go, within the tumor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results